Please login to the form below

Not currently logged in
Email:
Password:

Perjeta

This page shows the latest Perjeta news and features for those working in and with pharma, biotech and healthcare.

Mylan, Biocon’s Herceptin biosimilar launched in US

Mylan, Biocon’s Herceptin biosimilar launched in US

To counteract the onslaught from these biosimilars, Roche has  prepped filings for a fixed-dose combination of both Herceptin and its other antibody blockbuster Perjeta (pertuzumab), promising simpler dosing of the ... minutes. Currently, Herceptin and

Latest news

More from news
Approximately 20 fully matching, plus 49 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics